Clinical-Genomic Risk Group Classification of Suspicious Lesions on Prostate Multiparametric-MRI
Source check: Source checked. Not independent scientific confirmation.
Finding: Adaptive-LASSO and logistic models used prostate MRI and clinical features to distinguish low-risk biopsy lesions in a selected trial-derived cohort. The best reported AUC was 0.95.
Technology: Habitat-risk segmentation and radiomics with adaptive-LASSO/logistic models classified low-risk prostate lesions from pre-biopsy clinical/MRI features; 231 cores/78 men and bootstrap optimism correction, best AUC .95. Small selected trial-derived cohort, no external validation.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Habitat-risk segmentation and radiomics with adaptive-LASSO/logistic models classified low-risk prostate lesions from pre-biopsy clinical/MRI features; 231 cores/78 men and bootstrap optimism correction, best AUC .95. Small selected trial-derived cohort, no external validation.
- Test and result
- The analysis included 231 biopsy cores from 78 men and used bootstrap correction for model optimism.
- Limitation / still unknown
- A small selected cohort and internal resampling limit what the result establishes about other patients.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.mdpi.com/2072-6694/15/21/5240
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: other. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.